Croda launches highly purified amino acid series "BioXPro™" to support stable manufacturing and formulation processes for biopharmaceuticals.

AI Summary (NQ-processed)

Croda Japan Co., Ltd. has launched "BioXPro™," a series of highly purified amino acids designed to support stable manufacturing and formulation processes for biopharmaceuticals. This series combines Croda's advanced purification technology with insights gained from a partnership with Amino GmbH. It helps reduce lot-to-lot variability by strictly controlling levels of metals, elemental impurities, and endotoxins. Four types are available—arginine, arginine hydrochloride, histidine, and histidine hydrochloride—suitable for use from R&D to commercial manufacturing, and applicable across various processes such as cell culture, viral inactivation, and formulation.